Trial
NCT03014804
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Northwest Biotherapeutics; Bristol-Myers Squibb; Brain Tumor Funders Collaborative
Condition
Giant Cell Glioblastoma
Intervention
autologous dendritic cells pulsed with tumor lysate antigen Vaccine
Why stopped
Final contract negotiations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-24